CONMED Corporation (CNMD) vs Tandem Diabetes Care, Inc. (TNDM)
- CONMED Corporation CNMD 46.72 −0.89%
- Tandem Diabetes Care, Inc. TNDM 16.17 −2.12%
CONMED Corporation and Tandem Diabetes Care, Inc. are both Medical Devices companies. CONMED Corporation is the larger, with a market value of $1.4B against $1.2B — 1.2× the size. Tandem Diabetes Care, Inc. has negative trailing earnings, so its P/E is not meaningful; CONMED Corporation trades at 25.3×. Tandem Diabetes Care, Inc. grew revenue faster over the last twelve months: 3.96% against 3.42%. CONMED Corporation has the higher net margin (4.12% vs −6.08%) and the higher return on invested capital (3.75% vs −10.3%). Across the 19 metrics below, CONMED Corporation leads on 13 and Tandem Diabetes Care, Inc. on 6.
Valuation
Profitability
| Metric | CNMD | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 55.79% | 56.01% | 56.01% |
| Operating margin | 8.04% | (4.40%) | (15.03%) |
| Net margin | 4.12% | (6.08%) | (20.40%) |
| Free cash flow margin | 9.80% | (2.56%) | (7.24%) |
| Return on equity | 5.53% | (48.03%) | (15.32%) |
| Return on assets | 2.44% | (6.24%) | (19.72%) |
| Return on invested capital | 3.75% | (10.33%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack